Historical record - last NADAC effective date: 8/21/2024
Product Information
LOHIST-D LIQUID is a generic product labeled by Larken Laboratories, Inc., priced at $0.0587 per ML under NDC 68047012016. Its NADAC has been published 275 times since Mar 19, 2014.
Strength
2; 30 mg/5mL; mg/5mL
Manufacturer
Larken Laboratories, Inc.NDC
68047012016
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/15/2003
Pharmacological Classes
Price Statistics
The NADAC for LOHIST-D LIQUID has been published 275 times since Mar 19, 2014, and over the history we have for it it has risen 33.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0587 per ML |
|---|---|
| All-time high | $0.0589 (Aug 14, 2024) |
| All-time low | $0.0432 (Oct 19, 2016) |
| Median price | $0.0467 |
| Average price | $0.0487 |
| Largest weekly change | +18.4% (Jul 17, 2024) |
| Weeks tracked | 275 |
| Tracking since | Mar 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+17.9%
5Y
+17.9%
All
+33.4%
Last surveyed Aug 13, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlorpheniramine Maleate / Pseudoephedrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Larken Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpheniramine Maleate / Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOHIST-D LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for LOHIST-D LIQUID, manufactured by Larken Laboratories, Inc., is $0.0587 per ML (NDC 68047012016), effective Aug 13, 2025.
How has the price of LOHIST-D LIQUID changed over time?
Over the history we have for it, the NADAC for LOHIST-D LIQUID has risen 33.4%. It has been tracked across 275 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for LOHIST-D LIQUID?
Since Mar 19, 2014, the NADAC for LOHIST-D LIQUID has ranged from a low of $0.0432 (Oct 19, 2016) to a high of $0.0589 (Aug 14, 2024), with a median of $0.0467 per ML.
Are there cheaper alternatives to LOHIST-D LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of LOHIST-D LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOHIST-D LIQUID?
LOHIST-D LIQUID (NDC 68047012016) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.